

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | locomotory exploration behavior (GO:0035641) | 4.62477427 |
| 2 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.44784513 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.41040669 |
| 4 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.38618979 |
| 5 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.25713429 |
| 6 | response to muramyl dipeptide (GO:0032495) | 4.12761173 |
| 7 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.04196904 |
| 8 | vocalization behavior (GO:0071625) | 3.96387700 |
| 9 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.96058963 |
| 10 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.81712197 |
| 11 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.72410500 |
| 12 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.69190876 |
| 13 | synaptic vesicle maturation (GO:0016188) | 3.64316082 |
| 14 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.55317330 |
| 15 | regulation of synapse structural plasticity (GO:0051823) | 3.55121942 |
| 16 | response to peptidoglycan (GO:0032494) | 3.46436029 |
| 17 | dendritic spine organization (GO:0097061) | 3.46168484 |
| 18 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.43667310 |
| 19 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.43603069 |
| 20 | synaptic transmission, glutamatergic (GO:0035249) | 3.43396068 |
| 21 | protein localization to synapse (GO:0035418) | 3.35892778 |
| 22 | tolerance induction (GO:0002507) | 3.33697172 |
| 23 | glutamate secretion (GO:0014047) | 3.33300360 |
| 24 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.32772811 |
| 25 | exploration behavior (GO:0035640) | 3.31513414 |
| 26 | glutamate receptor signaling pathway (GO:0007215) | 3.27623231 |
| 27 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.26744295 |
| 28 | mannose metabolic process (GO:0006013) | 3.24621985 |
| 29 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.19680620 |
| 30 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.18885006 |
| 31 | dendritic spine morphogenesis (GO:0060997) | 3.18444503 |
| 32 | synaptic vesicle exocytosis (GO:0016079) | 3.14904416 |
| 33 | regulation of synaptic plasticity (GO:0048167) | 3.10958155 |
| 34 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.09654560 |
| 35 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.07734769 |
| 36 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.05247492 |
| 37 | long term synaptic depression (GO:0060292) | 3.04709355 |
| 38 | positive regulation of Rap GTPase activity (GO:0032854) | 3.04245338 |
| 39 | germinal center formation (GO:0002467) | 3.04036062 |
| 40 | negative regulation of interleukin-12 production (GO:0032695) | 3.02496607 |
| 41 | long-term memory (GO:0007616) | 2.97061386 |
| 42 | neuron-neuron synaptic transmission (GO:0007270) | 2.95159932 |
| 43 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.93731282 |
| 44 | regulation of postsynaptic membrane potential (GO:0060078) | 2.92747158 |
| 45 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.92474478 |
| 46 | response to laminar fluid shear stress (GO:0034616) | 2.92278895 |
| 47 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.91746108 |
| 48 | long-term synaptic potentiation (GO:0060291) | 2.87968250 |
| 49 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.87556702 |
| 50 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.85729626 |
| 51 | positive thymic T cell selection (GO:0045059) | 2.85691838 |
| 52 | regulation of p38MAPK cascade (GO:1900744) | 2.84735992 |
| 53 | regulation of gamma-delta T cell activation (GO:0046643) | 2.84447713 |
| 54 | synaptic vesicle endocytosis (GO:0048488) | 2.83523542 |
| 55 | activation of MAPKKK activity (GO:0000185) | 2.83318398 |
| 56 | regulation of synaptic vesicle transport (GO:1902803) | 2.80974811 |
| 57 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.80718871 |
| 58 | positive regulation of neurotransmitter transport (GO:0051590) | 2.80712540 |
| 59 | positive regulation of synapse maturation (GO:0090129) | 2.79156283 |
| 60 | positive regulation of type 2 immune response (GO:0002830) | 2.78217793 |
| 61 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.77623411 |
| 62 | positive regulation of dendrite morphogenesis (GO:0050775) | 2.77288748 |
| 63 | glycosphingolipid biosynthetic process (GO:0006688) | 2.75119442 |
| 64 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.75025774 |
| 65 | positive regulation of membrane potential (GO:0045838) | 2.72182607 |
| 66 | proline transport (GO:0015824) | 2.72031463 |
| 67 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.71874243 |
| 68 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.69114206 |
| 69 | detection of calcium ion (GO:0005513) | 2.68490367 |
| 70 | regulation of ARF protein signal transduction (GO:0032012) | 2.67903277 |
| 71 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.66745659 |
| 72 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.66666296 |
| 73 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.65229349 |
| 74 | establishment of endothelial barrier (GO:0061028) | 2.63951896 |
| 75 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.61736781 |
| 76 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.61283568 |
| 77 | response to pheromone (GO:0019236) | 2.58683216 |
| 78 | regulation of dendritic spine development (GO:0060998) | 2.57200633 |
| 79 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.56625148 |
| 80 | macrophage activation involved in immune response (GO:0002281) | 2.56219460 |
| 81 | regulation of vesicle fusion (GO:0031338) | 2.55884036 |
| 82 | regulation of synapse maturation (GO:0090128) | 2.54609801 |
| 83 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.54115826 |
| 84 | mature B cell differentiation involved in immune response (GO:0002313) | 2.52893402 |
| 85 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.51454087 |
| 86 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.50856187 |
| 87 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.50585350 |
| 88 | presynaptic membrane assembly (GO:0097105) | 2.50573234 |
| 89 | neuronal ion channel clustering (GO:0045161) | 2.49246561 |
| 90 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.48433516 |
| 91 | endothelium development (GO:0003158) | 2.48000404 |
| 92 | neutrophil activation involved in immune response (GO:0002283) | 2.47863380 |
| 93 | behavioral fear response (GO:0001662) | 2.47100376 |
| 94 | behavioral defense response (GO:0002209) | 2.47100376 |
| 95 | presynaptic membrane organization (GO:0097090) | 2.45908194 |
| 96 | signal complex assembly (GO:0007172) | 2.45736150 |
| 97 | positive regulation of fibroblast migration (GO:0010763) | 2.45655154 |
| 98 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.42063457 |
| 99 | cAMP catabolic process (GO:0006198) | 2.41587590 |
| 100 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.40552297 |
| 101 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.39785036 |
| 102 | axon extension involved in axon guidance (GO:0048846) | 2.39785036 |
| 103 | regulation of type 2 immune response (GO:0002828) | 2.38391036 |
| 104 | negative regulation of cell killing (GO:0031342) | 2.38389439 |
| 105 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.38389439 |
| 106 | response to amphetamine (GO:0001975) | 2.38192355 |
| 107 | cellular extravasation (GO:0045123) | 2.37765394 |
| 108 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.37491662 |
| 109 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.37141687 |
| 110 | postsynaptic membrane organization (GO:0001941) | 2.36971739 |
| 111 | immunoglobulin mediated immune response (GO:0016064) | 2.36152276 |
| 112 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.35970980 |
| 113 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.35797983 |
| 114 | positive regulation of dendrite development (GO:1900006) | 2.35398195 |
| 115 | NIK/NF-kappaB signaling (GO:0038061) | 2.35300523 |
| 116 | negative regulation of granulocyte differentiation (GO:0030853) | 2.35070664 |
| 117 | neuron recognition (GO:0008038) | 2.34357553 |
| 118 | chemical homeostasis within a tissue (GO:0048875) | 2.34170917 |
| 119 | positive regulation of dendritic spine development (GO:0060999) | 2.33732108 |
| 120 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.33591595 |
| 121 | endothelial cell chemotaxis (GO:0035767) | 2.32928885 |
| 122 | regulation of T cell tolerance induction (GO:0002664) | 2.32728972 |
| 123 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.31828409 |
| 124 | cellular response to epinephrine stimulus (GO:0071872) | 2.31753793 |
| 125 | cell communication by electrical coupling (GO:0010644) | 2.31691243 |
| 126 | myeloid dendritic cell differentiation (GO:0043011) | 2.31307336 |
| 127 | positive T cell selection (GO:0043368) | 2.30826158 |
| 128 | regulation of germinal center formation (GO:0002634) | 2.30659932 |
| 129 | learning (GO:0007612) | 2.30643219 |
| 130 | regulation of tolerance induction (GO:0002643) | 2.30214630 |
| 131 | axonal fasciculation (GO:0007413) | 2.28880552 |
| 132 | angiogenesis involved in wound healing (GO:0060055) | 2.28451062 |
| 133 | adenosine receptor signaling pathway (GO:0001973) | 2.27947156 |
| 134 | detection of other organism (GO:0098543) | 2.27616672 |
| 135 | glial cell proliferation (GO:0014009) | 2.27274994 |
| 136 | negative regulation of interleukin-6 production (GO:0032715) | 2.27112116 |
| 137 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.26787875 |
| 138 | thymic T cell selection (GO:0045061) | 2.25751463 |
| 139 | membrane depolarization (GO:0051899) | 2.25295899 |
| 140 | defense response to protozoan (GO:0042832) | 2.24089800 |
| 141 | fear response (GO:0042596) | 2.23490353 |
| 142 | regulation of ARF GTPase activity (GO:0032312) | 2.23483398 |
| 143 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.23336987 |
| 144 | sialylation (GO:0097503) | 2.23321998 |
| 145 | regulation of Rap GTPase activity (GO:0032317) | 2.23137203 |
| 146 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.22998371 |
| 147 | regulation of mast cell degranulation (GO:0043304) | 2.22803212 |
| 148 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.22662118 |
| 149 | response to auditory stimulus (GO:0010996) | 2.21987316 |
| 150 | ephrin receptor signaling pathway (GO:0048013) | 2.21574576 |
| 151 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.21514593 |
| 152 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.21345090 |
| 153 | regulation of leukocyte degranulation (GO:0043300) | 2.21123212 |
| 154 | T cell selection (GO:0045058) | 2.20597981 |
| 155 | regulation of neurotransmitter secretion (GO:0046928) | 2.19722257 |
| 156 | macrophage activation (GO:0042116) | 2.19085039 |
| 157 | positive regulation by symbiont of host defense response (GO:0052509) | 2.18629863 |
| 158 | modulation by symbiont of host defense response (GO:0052031) | 2.18629863 |
| 159 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.18629863 |
| 160 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.18629863 |
| 161 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.18629863 |
| 162 | modulation by symbiont of host immune response (GO:0052553) | 2.18629863 |
| 163 | cAMP biosynthetic process (GO:0006171) | 2.18050909 |
| 164 | positive regulation of synaptic transmission (GO:0050806) | 2.18022116 |
| 165 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.17556007 |
| 166 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.17270629 |
| 167 | regulation of antigen processing and presentation (GO:0002577) | 2.16835759 |
| 168 | response to fluid shear stress (GO:0034405) | 2.16358767 |
| 169 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.16082861 |
| 170 | detection of bacterium (GO:0016045) | 2.15925896 |
| 171 | T-helper 1 type immune response (GO:0042088) | 2.15200345 |
| 172 | neuronal action potential propagation (GO:0019227) | 2.14374596 |
| 173 | regulation of synaptic transmission (GO:0050804) | 2.14127765 |
| 174 | chemosensory behavior (GO:0007635) | 2.13890458 |
| 175 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.13161081 |
| 176 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.12857469 |
| 177 | mature B cell differentiation (GO:0002335) | 2.11429487 |
| 178 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.11394347 |
| 179 | negative regulation of innate immune response (GO:0045824) | 2.10713124 |
| 180 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.10626554 |
| 181 | regulation of phosphatidylinositol 3-kinase activity (GO:0043551) | 2.09948837 |
| 182 | positive regulation of antigen processing and presentation (GO:0002579) | 2.09671574 |
| 183 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.09655019 |
| 184 | positive regulation of tolerance induction (GO:0002645) | 2.09198216 |
| 185 | myeloid dendritic cell activation (GO:0001773) | 2.09095685 |
| 186 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.08292927 |
| 187 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.07816808 |
| 188 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.07751895 |
| 189 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.07277953 |
| 190 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.07272766 |
| 191 | positive regulation of mast cell degranulation (GO:0043306) | 2.07272766 |
| 192 | T cell migration (GO:0072678) | 2.07167649 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.71516073 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.26288157 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.17923542 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.97740543 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.78241717 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.73673866 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.71174896 |
| 8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.67568649 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.65003863 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.65003863 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.54007366 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.51711686 |
| 13 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.50372930 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.44139584 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.39714729 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.35676004 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.32167550 |
| 18 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.30989148 |
| 19 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.27577418 |
| 20 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.20947211 |
| 21 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.18686021 |
| 22 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.13658764 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.09565335 |
| 24 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.05559179 |
| 25 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.04291494 |
| 26 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.03783715 |
| 27 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.02915820 |
| 28 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.02514020 |
| 29 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.02175480 |
| 30 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.01820686 |
| 31 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.01650719 |
| 32 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.00568125 |
| 33 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.98093288 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.83366459 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.79969941 |
| 36 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.76066490 |
| 37 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.75021333 |
| 38 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.73553970 |
| 39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.72768657 |
| 40 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.72227552 |
| 41 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.71708260 |
| 42 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.71284029 |
| 43 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.66480351 |
| 44 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.66146320 |
| 45 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.65924539 |
| 46 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.63346451 |
| 47 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.63216255 |
| 48 | MYC_22102868_ChIP-Seq_BL_Human | 1.61676169 |
| 49 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.61003317 |
| 50 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.59954985 |
| 51 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.57276573 |
| 52 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.56813912 |
| 53 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.55619136 |
| 54 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.54914544 |
| 55 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.50410031 |
| 56 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.50318146 |
| 57 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.49347861 |
| 58 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.49160715 |
| 59 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48484697 |
| 60 | MAF_26560356_Chip-Seq_TH1_Human | 1.46585073 |
| 61 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.44031123 |
| 62 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.43961874 |
| 63 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.43504245 |
| 64 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.41845903 |
| 65 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.41483948 |
| 66 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.41286844 |
| 67 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.40445695 |
| 68 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.38466469 |
| 69 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.38207322 |
| 70 | SPI1_23127762_ChIP-Seq_K562_Human | 1.37935649 |
| 71 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.36987784 |
| 72 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.36531718 |
| 73 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.36102087 |
| 74 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.35420263 |
| 75 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.32839588 |
| 76 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.31343067 |
| 77 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.30753763 |
| 78 | UTX_26944678_Chip-Seq_JUKART_Human | 1.29430503 |
| 79 | TP53_16413492_ChIP-PET_HCT116_Human | 1.27599246 |
| 80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.26884689 |
| 81 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.25999307 |
| 82 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.23137997 |
| 83 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.21203041 |
| 84 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.21145677 |
| 85 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.21016696 |
| 86 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.20429648 |
| 87 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20426326 |
| 88 | * MAF_26560356_Chip-Seq_TH2_Human | 1.19578223 |
| 89 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.17094984 |
| 90 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.16785130 |
| 91 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16641221 |
| 92 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.16528614 |
| 93 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16118814 |
| 94 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.15286128 |
| 95 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15286128 |
| 96 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14628559 |
| 97 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.14385025 |
| 98 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.13617461 |
| 99 | RXR_22108803_ChIP-Seq_LS180_Human | 1.13351851 |
| 100 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.10989809 |
| 101 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.10902914 |
| 102 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.10449087 |
| 103 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.10388869 |
| 104 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.10282252 |
| 105 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.10198860 |
| 106 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10001900 |
| 107 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09617820 |
| 108 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.09559682 |
| 109 | AR_19668381_ChIP-Seq_PC3_Human | 1.09353257 |
| 110 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.07467069 |
| 111 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.07279542 |
| 112 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.07093509 |
| 113 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.06454104 |
| 114 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.06070545 |
| 115 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05429447 |
| 116 | P300_19829295_ChIP-Seq_ESCs_Human | 1.05331122 |
| 117 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.04654421 |
| 118 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.04454297 |
| 119 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.04160478 |
| 120 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.03928323 |
| 121 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.03928323 |
| 122 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.03350574 |
| 123 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.03235292 |
| 124 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.02672925 |
| 125 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.01789224 |
| 126 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01216839 |
| 127 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.00935266 |
| 128 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99908225 |
| 129 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.99359237 |
| 130 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.99338732 |
| 131 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.99170403 |
| 132 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98302011 |
| 133 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97933285 |
| 134 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97896788 |
| 135 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.97328982 |
| 136 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96336443 |
| 137 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.95506282 |
| 138 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.95236315 |
| 139 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94025774 |
| 140 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.93995653 |
| 141 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.93937395 |
| 142 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93930271 |
| 143 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.93441780 |
| 144 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.93220759 |
| 145 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.92951192 |
| 146 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.92938818 |
| 147 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.92541518 |
| 148 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.92057125 |
| 149 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.90383098 |
| 150 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.90375205 |
| 151 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.90324057 |
| 152 | STAT3_23295773_ChIP-Seq_U87_Human | 0.90253289 |
| 153 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.90199133 |
| 154 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.89940398 |
| 155 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.88871820 |
| 156 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.88545135 |
| 157 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.88457273 |
| 158 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87793394 |
| 159 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.87553287 |
| 160 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87184395 |
| 161 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.86530152 |
| 162 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.86437900 |
| 163 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.86360630 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.43617523 |
| 2 | MP0003436_decreased_susceptibility_to | 3.37376088 |
| 3 | MP0004510_myositis | 3.30807904 |
| 4 | MP0003880_abnormal_central_pattern | 3.25804880 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 3.18434251 |
| 6 | MP0003724_increased_susceptibility_to | 3.15004832 |
| 7 | * MP0009745_abnormal_behavioral_response | 2.76329272 |
| 8 | MP0002822_catalepsy | 2.71120445 |
| 9 | * MP0002063_abnormal_learning/memory/cond | 2.68344051 |
| 10 | MP0003787_abnormal_imprinting | 2.53929060 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.48310738 |
| 12 | MP0003172_abnormal_lysosome_physiology | 2.46090842 |
| 13 | MP0001188_hyperpigmentation | 2.45023047 |
| 14 | MP0009278_abnormal_bone_marrow | 2.36357778 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.21220830 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.18937267 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.18335613 |
| 18 | MP0002572_abnormal_emotion/affect_behav | 2.12270749 |
| 19 | MP0005167_abnormal_blood-brain_barrier | 2.07250635 |
| 20 | MP0002064_seizures | 2.03033205 |
| 21 | MP0002419_abnormal_innate_immunity | 1.97676399 |
| 22 | MP0002933_joint_inflammation | 1.91084406 |
| 23 | MP0001968_abnormal_touch/_nociception | 1.87140472 |
| 24 | MP0001533_abnormal_skeleton_physiology | 1.85078128 |
| 25 | MP0006082_CNS_inflammation | 1.80287659 |
| 26 | MP0001486_abnormal_startle_reflex | 1.79872511 |
| 27 | MP0001790_abnormal_immune_system | 1.79767541 |
| 28 | MP0005387_immune_system_phenotype | 1.79767541 |
| 29 | MP0004947_skin_inflammation | 1.74173869 |
| 30 | MP0001800_abnormal_humoral_immune | 1.73484400 |
| 31 | MP0005025_abnormal_response_to | 1.71909068 |
| 32 | MP0005623_abnormal_meninges_morphology | 1.71130665 |
| 33 | MP0002736_abnormal_nociception_after | 1.67117178 |
| 34 | MP0008004_abnormal_stomach_pH | 1.64029222 |
| 35 | MP0009840_abnormal_foam_cell | 1.63038380 |
| 36 | MP0002723_abnormal_immune_serum | 1.62725307 |
| 37 | MP0004270_analgesia | 1.61066709 |
| 38 | MP0002452_abnormal_antigen_presenting | 1.59810799 |
| 39 | MP0002735_abnormal_chemical_nociception | 1.57112005 |
| 40 | MP0003941_abnormal_skin_development | 1.57062464 |
| 41 | MP0005310_abnormal_salivary_gland | 1.54836686 |
| 42 | MP0003045_fibrosis | 1.53176176 |
| 43 | MP0000685_abnormal_immune_system | 1.52746511 |
| 44 | MP0009785_altered_susceptibility_to | 1.51313314 |
| 45 | MP0002420_abnormal_adaptive_immunity | 1.49499394 |
| 46 | MP0001819_abnormal_immune_cell | 1.47869748 |
| 47 | MP0003690_abnormal_glial_cell | 1.44044225 |
| 48 | MP0002272_abnormal_nervous_system | 1.42587713 |
| 49 | MP0001440_abnormal_grooming_behavior | 1.41801069 |
| 50 | MP0004858_abnormal_nervous_system | 1.40819535 |
| 51 | MP0001851_eye_inflammation | 1.38952971 |
| 52 | MP0003763_abnormal_thymus_physiology | 1.38807494 |
| 53 | MP0004484_altered_response_of | 1.38034047 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.36360543 |
| 55 | MP0008260_abnormal_autophagy | 1.35528713 |
| 56 | MP0005423_abnormal_somatic_nervous | 1.35414891 |
| 57 | MP0003828_pulmonary_edema | 1.32407393 |
| 58 | MP0009764_decreased_sensitivity_to | 1.31537646 |
| 59 | MP0001879_abnormal_lymphatic_vessel | 1.30249344 |
| 60 | MP0001545_abnormal_hematopoietic_system | 1.30102222 |
| 61 | MP0005397_hematopoietic_system_phenotyp | 1.30102222 |
| 62 | MP0001986_abnormal_taste_sensitivity | 1.29958042 |
| 63 | MP0010368_abnormal_lymphatic_system | 1.29827386 |
| 64 | MP0003879_abnormal_hair_cell | 1.29610807 |
| 65 | MP0005171_absent_coat_pigmentation | 1.28441780 |
| 66 | MP0002405_respiratory_system_inflammati | 1.26156219 |
| 67 | MP0000465_gastrointestinal_hemorrhage | 1.26091777 |
| 68 | MP0000604_amyloidosis | 1.24912013 |
| 69 | MP0009046_muscle_twitch | 1.23543594 |
| 70 | MP0000249_abnormal_blood_vessel | 1.22395286 |
| 71 | MP0000569_abnormal_digit_pigmentation | 1.22020959 |
| 72 | MP0002332_abnormal_exercise_endurance | 1.21034061 |
| 73 | MP0002557_abnormal_social/conspecific_i | 1.20555325 |
| 74 | MP0000678_abnormal_parathyroid_gland | 1.16910213 |
| 75 | MP0004130_abnormal_muscle_cell | 1.16849582 |
| 76 | MP0008961_abnormal_basal_metabolism | 1.15718177 |
| 77 | MP0002877_abnormal_melanocyte_morpholog | 1.15558762 |
| 78 | MP0005535_abnormal_body_temperature | 1.15437751 |
| 79 | MP0000343_altered_response_to | 1.15305266 |
| 80 | MP0001346_abnormal_lacrimal_gland | 1.13765952 |
| 81 | MP0003122_maternal_imprinting | 1.13167996 |
| 82 | MP0004811_abnormal_neuron_physiology | 1.11138311 |
| 83 | MP0003075_altered_response_to | 1.11051216 |
| 84 | MP0002163_abnormal_gland_morphology | 1.09491752 |
| 85 | MP0006292_abnormal_olfactory_placode | 1.09398879 |
| 86 | MP0000751_myopathy | 1.08204483 |
| 87 | MP0005377_hearing/vestibular/ear_phenot | 1.07766783 |
| 88 | MP0003878_abnormal_ear_physiology | 1.07766783 |
| 89 | MP0005646_abnormal_pituitary_gland | 1.07473088 |
| 90 | MP0001845_abnormal_inflammatory_respons | 1.07383461 |
| 91 | MP0000716_abnormal_immune_system | 1.06993017 |
| 92 | MP0003329_amyloid_beta_deposits | 1.06869165 |
| 93 | MP0005464_abnormal_platelet_physiology | 1.06708867 |
| 94 | MP0001502_abnormal_circadian_rhythm | 1.06166922 |
| 95 | MP0005165_increased_susceptibility_to | 1.04909741 |
| 96 | MP0004085_abnormal_heartbeat | 1.04438178 |
| 97 | MP0000920_abnormal_myelination | 1.03519713 |
| 98 | MP0005390_skeleton_phenotype | 1.03033456 |
| 99 | MP0005645_abnormal_hypothalamus_physiol | 1.02216909 |
| 100 | MP0002009_preneoplasia | 1.01758477 |
| 101 | MP0001542_abnormal_bone_strength | 0.98829422 |
| 102 | MP0002398_abnormal_bone_marrow | 0.97378500 |
| 103 | MP0005595_abnormal_vascular_smooth | 0.96454677 |
| 104 | MP0002184_abnormal_innervation | 0.96415821 |
| 105 | MP0003705_abnormal_hypodermis_morpholog | 0.95571110 |
| 106 | MP0001348_abnormal_lacrimal_gland | 0.95535765 |
| 107 | MP0003191_abnormal_cellular_cholesterol | 0.93255697 |
| 108 | MP0001958_emphysema | 0.93195426 |
| 109 | MP0006138_congestive_heart_failure | 0.90470385 |
| 110 | MP0003303_peritoneal_inflammation | 0.89488803 |
| 111 | MP0002734_abnormal_mechanical_nocicepti | 0.89284984 |
| 112 | MP0008569_lethality_at_weaning | 0.89137406 |
| 113 | MP0003448_altered_tumor_morphology | 0.88908998 |
| 114 | MP0005367_renal/urinary_system_phenotyp | 0.88634082 |
| 115 | MP0000516_abnormal_urinary_system | 0.88634082 |
| 116 | MP0008469_abnormal_protein_level | 0.88358585 |
| 117 | MP0005164_abnormal_response_to | 0.87949135 |
| 118 | MP0005670_abnormal_white_adipose | 0.87296716 |
| 119 | MP0004883_abnormal_blood_vessel | 0.86971389 |
| 120 | MP0002067_abnormal_sensory_capabilities | 0.85921511 |
| 121 | MP0003119_abnormal_digestive_system | 0.85136108 |
| 122 | MP0002277_abnormal_respiratory_mucosa | 0.83023831 |
| 123 | MP0005076_abnormal_cell_differentiation | 0.82258764 |
| 124 | MP0009780_abnormal_chondrocyte_physiolo | 0.82047043 |
| 125 | MP0000858_altered_metastatic_potential | 0.82007756 |
| 126 | MP0005666_abnormal_adipose_tissue | 0.80605107 |
| 127 | MP0003385_abnormal_body_wall | 0.80291937 |
| 128 | MP0000778_abnormal_nervous_system | 0.79825463 |
| 129 | MP0005257_abnormal_intraocular_pressure | 0.78228714 |
| 130 | MP0004133_heterotaxia | 0.77385143 |
| 131 | MP0001664_abnormal_digestion | 0.77198783 |
| 132 | MP0005409_darkened_coat_color | 0.77161004 |
| 133 | MP0004036_abnormal_muscle_relaxation | 0.77098726 |
| 134 | MP0004084_abnormal_cardiac_muscle | 0.76043949 |
| 135 | MP0008874_decreased_physiological_sensi | 0.76009611 |
| 136 | MP0003633_abnormal_nervous_system | 0.74896291 |
| 137 | MP0002909_abnormal_adrenal_gland | 0.74344179 |
| 138 | * MP0001970_abnormal_pain_threshold | 0.73965747 |
| 139 | MP0003091_abnormal_cell_migration | 0.72609837 |
| 140 | MP0002733_abnormal_thermal_nociception | 0.71644004 |
| 141 | MP0010234_abnormal_vibrissa_follicle | 0.70640772 |
| 142 | MP0004742_abnormal_vestibular_system | 0.70627294 |
| 143 | MP0002066_abnormal_motor_capabilities/c | 0.68852651 |
| 144 | MP0004885_abnormal_endolymph | 0.68802822 |
| 145 | MP0002138_abnormal_hepatobiliary_system | 0.67322514 |
| 146 | MP0000015_abnormal_ear_pigmentation | 0.67262782 |
| 147 | MP0002925_abnormal_cardiovascular_devel | 0.66122096 |
| 148 | MP0003121_genomic_imprinting | 0.65277627 |
| 149 | MP0000955_abnormal_spinal_cord | 0.64648591 |
| 150 | MP0002882_abnormal_neuron_morphology | 0.63203294 |
| 151 | MP0001853_heart_inflammation | 0.62643079 |
| 152 | MP0001177_atelectasis | 0.62393101 |
| 153 | MP0000681_abnormal_thyroid_gland | 0.62208107 |
| 154 | MP0002254_reproductive_system_inflammat | 0.61093861 |
| 155 | MP0002148_abnormal_hypersensitivity_rea | 0.60652576 |
| 156 | MP0005166_decreased_susceptibility_to | 0.60430510 |
| 157 | MP0003279_aneurysm | 0.60324906 |
| 158 | MP0008995_early_reproductive_senescence | 0.60202289 |
| 159 | MP0001835_abnormal_antigen_presentation | 0.59672453 |
| 160 | MP0010352_gastrointestinal_tract_polyps | 0.59460901 |
| 161 | MP0005187_abnormal_penis_morphology | 0.57736775 |
| 162 | MP0002152_abnormal_brain_morphology | 0.56546715 |
| 163 | MP0002249_abnormal_larynx_morphology | 0.56327651 |
| 164 | MP0002998_abnormal_bone_remodeling | 0.55538082 |
| 165 | MP0005671_abnormal_response_to | 0.54845592 |
| 166 | MP0000767_abnormal_smooth_muscle | 0.54056452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.90018801 |
| 2 | Febrile seizures (HP:0002373) | 3.88246409 |
| 3 | Myokymia (HP:0002411) | 3.83066936 |
| 4 | Focal seizures (HP:0007359) | 3.65360127 |
| 5 | Epileptic encephalopathy (HP:0200134) | 3.61749985 |
| 6 | Dysostosis multiplex (HP:0000943) | 3.32620103 |
| 7 | Atonic seizures (HP:0010819) | 3.29218664 |
| 8 | Visual hallucinations (HP:0002367) | 3.20163381 |
| 9 | Eczematoid dermatitis (HP:0000976) | 3.19134249 |
| 10 | Spontaneous hematomas (HP:0007420) | 3.00073905 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 2.91687124 |
| 12 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.91687124 |
| 13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.91687124 |
| 14 | Asymmetric septal hypertrophy (HP:0001670) | 2.91617891 |
| 15 | Amyloidosis (HP:0011034) | 2.87219012 |
| 16 | Supranuclear gaze palsy (HP:0000605) | 2.86675952 |
| 17 | Stomatitis (HP:0010280) | 2.86461954 |
| 18 | Absent eyebrow (HP:0002223) | 2.84248016 |
| 19 | Systemic lupus erythematosus (HP:0002725) | 2.77872191 |
| 20 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.74584867 |
| 21 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.74584867 |
| 22 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.74584867 |
| 23 | Papilledema (HP:0001085) | 2.73345657 |
| 24 | Amelogenesis imperfecta (HP:0000705) | 2.73253024 |
| 25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.73042632 |
| 26 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.70486516 |
| 27 | Mucopolysacchariduria (HP:0008155) | 2.70486516 |
| 28 | Neurofibrillary tangles (HP:0002185) | 2.69644016 |
| 29 | Myositis (HP:0100614) | 2.68546716 |
| 30 | Increased cerebral lipofuscin (HP:0011813) | 2.63199637 |
| 31 | Abnormality of macrophages (HP:0004311) | 2.58929545 |
| 32 | Amblyopia (HP:0000646) | 2.53639567 |
| 33 | Distal lower limb amyotrophy (HP:0008944) | 2.51747144 |
| 34 | Interstitial pulmonary disease (HP:0006530) | 2.44827543 |
| 35 | Absence seizures (HP:0002121) | 2.44379483 |
| 36 | Lower limb amyotrophy (HP:0007210) | 2.44153902 |
| 37 | Retrobulbar optic neuritis (HP:0100654) | 2.43745882 |
| 38 | Optic neuritis (HP:0100653) | 2.43745882 |
| 39 | Orchitis (HP:0100796) | 2.42479582 |
| 40 | Annular pancreas (HP:0001734) | 2.42255407 |
| 41 | Abnormality of the lower motor neuron (HP:0002366) | 2.38707325 |
| 42 | Neuronal loss in central nervous system (HP:0002529) | 2.36077214 |
| 43 | Colitis (HP:0002583) | 2.34672315 |
| 44 | Primary atrial arrhythmia (HP:0001692) | 2.34341264 |
| 45 | Muscle fiber splitting (HP:0003555) | 2.31484813 |
| 46 | Distal lower limb muscle weakness (HP:0009053) | 2.31062308 |
| 47 | Recurrent bacterial skin infections (HP:0005406) | 2.30932228 |
| 48 | Dialeptic seizures (HP:0011146) | 2.29568220 |
| 49 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.27931681 |
| 50 | Recurrent abscess formation (HP:0002722) | 2.27507765 |
| 51 | Absent speech (HP:0001344) | 2.26845361 |
| 52 | Slow saccadic eye movements (HP:0000514) | 2.25081884 |
| 53 | Progressive cerebellar ataxia (HP:0002073) | 2.23935265 |
| 54 | Unilateral renal agenesis (HP:0000122) | 2.22652176 |
| 55 | Polycythemia (HP:0001901) | 2.21008420 |
| 56 | Hyperventilation (HP:0002883) | 2.20905105 |
| 57 | Atrial fibrillation (HP:0005110) | 2.19995376 |
| 58 | Supraventricular arrhythmia (HP:0005115) | 2.18646749 |
| 59 | Mediastinal lymphadenopathy (HP:0100721) | 2.17281990 |
| 60 | Vasculitis (HP:0002633) | 2.16923452 |
| 61 | Peripheral hypomyelination (HP:0007182) | 2.16315066 |
| 62 | Loss of speech (HP:0002371) | 2.15990789 |
| 63 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.15430050 |
| 64 | Supraventricular tachycardia (HP:0004755) | 2.15369884 |
| 65 | Keratoconjunctivitis sicca (HP:0001097) | 2.13703154 |
| 66 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.12631839 |
| 67 | Increased IgE level (HP:0003212) | 2.11543444 |
| 68 | Aplasia cutis congenita (HP:0001057) | 2.11290699 |
| 69 | Increased variability in muscle fiber diameter (HP:0003557) | 2.10234921 |
| 70 | Axonal loss (HP:0003447) | 2.10172707 |
| 71 | Hemoptysis (HP:0002105) | 2.08723962 |
| 72 | Prolonged bleeding time (HP:0003010) | 2.08437417 |
| 73 | Spondylolisthesis (HP:0003302) | 2.07433271 |
| 74 | Broad face (HP:0000283) | 2.06976178 |
| 75 | Gastrointestinal stroma tumor (HP:0100723) | 2.03778015 |
| 76 | Milia (HP:0001056) | 2.03295972 |
| 77 | Joint stiffness (HP:0001387) | 2.03229749 |
| 78 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.03194399 |
| 79 | Apathy (HP:0000741) | 2.02079508 |
| 80 | Restrictive lung disease (HP:0002091) | 2.00850085 |
| 81 | Mutism (HP:0002300) | 2.00106107 |
| 82 | Protrusio acetabuli (HP:0003179) | 1.99500061 |
| 83 | Pulmonary infiltrates (HP:0002113) | 1.98828614 |
| 84 | Generalized tonic-clonic seizures (HP:0002069) | 1.98114210 |
| 85 | Pointed chin (HP:0000307) | 1.97656424 |
| 86 | Aortic aneurysm (HP:0004942) | 1.97071186 |
| 87 | Genetic anticipation (HP:0003743) | 1.95331315 |
| 88 | Emphysema (HP:0002097) | 1.93612085 |
| 89 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.92399802 |
| 90 | Keratoconjunctivitis (HP:0001096) | 1.90851203 |
| 91 | Nuclear cataract (HP:0100018) | 1.90583301 |
| 92 | Impaired smooth pursuit (HP:0007772) | 1.89714561 |
| 93 | Thin bony cortex (HP:0002753) | 1.89242133 |
| 94 | Diminished motivation (HP:0000745) | 1.88868279 |
| 95 | Large eyes (HP:0001090) | 1.87622528 |
| 96 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.86291807 |
| 97 | Cellulitis (HP:0100658) | 1.86234100 |
| 98 | Broad-based gait (HP:0002136) | 1.86136189 |
| 99 | Postural instability (HP:0002172) | 1.84024447 |
| 100 | Cerebral inclusion bodies (HP:0100314) | 1.83614396 |
| 101 | Deeply set eye (HP:0000490) | 1.83197646 |
| 102 | Abnormality of the parietal bone (HP:0002696) | 1.83022536 |
| 103 | Epistaxis (HP:0000421) | 1.81864351 |
| 104 | Abnormality of the fingertips (HP:0001211) | 1.80834893 |
| 105 | Gastrointestinal infarctions (HP:0005244) | 1.80762076 |
| 106 | Syncope (HP:0001279) | 1.80347423 |
| 107 | Absent eyelashes (HP:0000561) | 1.80071461 |
| 108 | Stereotypic behavior (HP:0000733) | 1.79847048 |
| 109 | Hyporeflexia of lower limbs (HP:0002600) | 1.79722341 |
| 110 | J-shaped sella turcica (HP:0002680) | 1.79410604 |
| 111 | Increased connective tissue (HP:0009025) | 1.79391945 |
| 112 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.79317206 |
| 113 | Aneurysm (HP:0002617) | 1.77601595 |
| 114 | Rapidly progressive (HP:0003678) | 1.77046632 |
| 115 | Ankyloglossia (HP:0010296) | 1.76799184 |
| 116 | Easy fatigability (HP:0003388) | 1.76705620 |
| 117 | Obstructive lung disease (HP:0006536) | 1.76085081 |
| 118 | Chronic obstructive pulmonary disease (HP:0006510) | 1.76085081 |
| 119 | Genu recurvatum (HP:0002816) | 1.75431375 |
| 120 | Purpura (HP:0000979) | 1.75294017 |
| 121 | Onion bulb formation (HP:0003383) | 1.74998465 |
| 122 | Complement deficiency (HP:0004431) | 1.74815244 |
| 123 | Ocular albinism (HP:0001107) | 1.74543116 |
| 124 | Inflammation of the large intestine (HP:0002037) | 1.73350244 |
| 125 | Follicular hyperkeratosis (HP:0007502) | 1.73199636 |
| 126 | Difficulty running (HP:0009046) | 1.72929864 |
| 127 | Difficulty climbing stairs (HP:0003551) | 1.71693914 |
| 128 | Depression (HP:0000716) | 1.71536269 |
| 129 | Recurrent fungal infections (HP:0002841) | 1.71158678 |
| 130 | Gastrointestinal inflammation (HP:0004386) | 1.70850997 |
| 131 | Diplopia (HP:0000651) | 1.70809257 |
| 132 | Abnormality of binocular vision (HP:0011514) | 1.70809257 |
| 133 | Abnormality of the periventricular white matter (HP:0002518) | 1.70752316 |
| 134 | Cerebral aneurysm (HP:0004944) | 1.70667578 |
| 135 | Porencephaly (HP:0002132) | 1.70046028 |
| 136 | Chest pain (HP:0100749) | 1.69586369 |
| 137 | Palpebral edema (HP:0100540) | 1.69156460 |
| 138 | Decreased circulating renin level (HP:0003351) | 1.68095375 |
| 139 | Hematochezia (HP:0002573) | 1.67542018 |
| 140 | Spinal canal stenosis (HP:0003416) | 1.66166598 |
| 141 | Ventricular fibrillation (HP:0001663) | 1.65563733 |
| 142 | Hypoventilation (HP:0002791) | 1.63784987 |
| 143 | Poor eye contact (HP:0000817) | 1.63263801 |
| 144 | Bradykinesia (HP:0002067) | 1.62994592 |
| 145 | Arterial tortuosity (HP:0005116) | 1.60935206 |
| 146 | Double outlet right ventricle (HP:0001719) | 1.60744242 |
| 147 | Congenital malformation of the right heart (HP:0011723) | 1.60744242 |
| 148 | Hemiplegia (HP:0002301) | 1.60623106 |
| 149 | Midline defect of the nose (HP:0004122) | 1.59555747 |
| 150 | Polygenic inheritance (HP:0010982) | 1.58679173 |
| 151 | Obsessive-compulsive behavior (HP:0000722) | 1.57450357 |
| 152 | Skull defect (HP:0001362) | 1.57401680 |
| 153 | Intestinal atresia (HP:0011100) | 1.54130854 |
| 154 | Onycholysis (HP:0001806) | 1.53565544 |
| 155 | Gaze-evoked nystagmus (HP:0000640) | 1.52774573 |
| 156 | Thickened helices (HP:0000391) | 1.52350055 |
| 157 | Supernumerary ribs (HP:0005815) | 1.52234354 |
| 158 | Abnormal EKG (HP:0003115) | 1.51825121 |
| 159 | Periorbital edema (HP:0100539) | 1.51598375 |
| 160 | Hyperactive renin-angiotensin system (HP:0000841) | 1.51072060 |
| 161 | Multifactorial inheritance (HP:0001426) | 1.50525243 |
| 162 | Resting tremor (HP:0002322) | 1.49806840 |
| 163 | Vertebral arch anomaly (HP:0008438) | 1.49495210 |
| 164 | Obstructive sleep apnea (HP:0002870) | 1.48658780 |
| 165 | Cutaneous finger syndactyly (HP:0010554) | 1.48607458 |
| 166 | Tented upper lip vermilion (HP:0010804) | 1.48593954 |
| 167 | Exotropia (HP:0000577) | 1.47880617 |
| 168 | Deep palmar crease (HP:0006191) | 1.47741622 |
| 169 | Spinal muscular atrophy (HP:0007269) | 1.47411084 |
| 170 | Vascular tortuosity (HP:0004948) | 1.46862157 |
| 171 | Action tremor (HP:0002345) | 1.46670451 |
| 172 | Abnormal atrioventricular conduction (HP:0005150) | 1.44486606 |
| 173 | Arterial thrombosis (HP:0004420) | 1.44420710 |
| 174 | Incomplete penetrance (HP:0003829) | 1.43431162 |
| 175 | Vertigo (HP:0002321) | 1.43110546 |
| 176 | Excessive salivation (HP:0003781) | 1.42719775 |
| 177 | Drooling (HP:0002307) | 1.42719775 |
| 178 | Urethral obstruction (HP:0000796) | 1.42606897 |
| 179 | Morphological abnormality of the middle ear (HP:0008609) | 1.42372230 |
| 180 | Atrophic scars (HP:0001075) | 1.42275946 |
| 181 | Heart block (HP:0012722) | 1.41909896 |
| 182 | Abnormality of the nasal septum (HP:0000419) | 1.41473718 |
| 183 | Dysmetria (HP:0001310) | 1.41293558 |
| 184 | Oligodontia (HP:0000677) | 1.41100016 |
| 185 | Heterochromia iridis (HP:0001100) | 1.40663661 |
| 186 | Sudden death (HP:0001699) | 1.40188923 |
| 187 | Abnormality of the antihelix (HP:0009738) | 1.39706696 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.24262777 |
| 2 | TIE1 | 3.89155515 |
| 3 | NTRK3 | 3.82449506 |
| 4 | RIPK4 | 3.48440919 |
| 5 | MAP3K13 | 3.40954658 |
| 6 | SIK3 | 2.61385169 |
| 7 | BMPR2 | 2.59144196 |
| 8 | MAP4K1 | 2.36969239 |
| 9 | MAP3K9 | 2.32333753 |
| 10 | SIK2 | 2.31766166 |
| 11 | PRPF4B | 2.28651628 |
| 12 | TRIB3 | 1.69710821 |
| 13 | PTK2B | 1.68919453 |
| 14 | FES | 1.67704091 |
| 15 | ZAP70 | 1.65745166 |
| 16 | MAP2K7 | 1.65686728 |
| 17 | DAPK2 | 1.65004681 |
| 18 | BLK | 1.59632850 |
| 19 | PLK2 | 1.59227073 |
| 20 | NTRK2 | 1.56160159 |
| 21 | TYK2 | 1.56151931 |
| 22 | DMPK | 1.54057840 |
| 23 | DAPK1 | 1.52286102 |
| 24 | TYRO3 | 1.48825064 |
| 25 | CDK12 | 1.46073334 |
| 26 | MAP2K3 | 1.41272456 |
| 27 | IRAK3 | 1.40042117 |
| 28 | PRKD3 | 1.40019801 |
| 29 | TGFBR2 | 1.35932333 |
| 30 | KSR1 | 1.32551019 |
| 31 | MAP3K11 | 1.29555526 |
| 32 | MAP3K14 | 1.27965005 |
| 33 | IRAK2 | 1.27343218 |
| 34 | TTN | 1.27025742 |
| 35 | FGR | 1.26340791 |
| 36 | MARK2 | 1.24137696 |
| 37 | FER | 1.21407690 |
| 38 | MAP3K4 | 1.20176981 |
| 39 | CSK | 1.19056645 |
| 40 | CAMK1 | 1.15834170 |
| 41 | MINK1 | 1.15810281 |
| 42 | SIK1 | 1.13326082 |
| 43 | ITK | 1.13022385 |
| 44 | ERN1 | 1.12216809 |
| 45 | IRAK4 | 1.12112625 |
| 46 | CASK | 1.09757266 |
| 47 | BTK | 1.08688151 |
| 48 | MAP3K12 | 1.08090173 |
| 49 | MAP3K3 | 1.02481435 |
| 50 | KSR2 | 1.01307772 |
| 51 | HIPK2 | 1.00382621 |
| 52 | CAMKK1 | 0.99854260 |
| 53 | CDK5 | 0.97300919 |
| 54 | UHMK1 | 0.97048319 |
| 55 | RIPK1 | 0.94418947 |
| 56 | EPHA2 | 0.94140471 |
| 57 | IKBKB | 0.93882250 |
| 58 | ALK | 0.92959437 |
| 59 | MAP3K7 | 0.92154487 |
| 60 | GRK5 | 0.90502518 |
| 61 | TEC | 0.87306557 |
| 62 | SYK | 0.86836804 |
| 63 | CHUK | 0.85812466 |
| 64 | IRAK1 | 0.85306026 |
| 65 | FGFR2 | 0.85175407 |
| 66 | PAK6 | 0.84220962 |
| 67 | ARAF | 0.83141078 |
| 68 | EPHB1 | 0.78055254 |
| 69 | CAMK4 | 0.77209379 |
| 70 | AKT3 | 0.76937938 |
| 71 | KIT | 0.76867519 |
| 72 | MAP2K4 | 0.76780667 |
| 73 | PDPK1 | 0.75270841 |
| 74 | MAPK4 | 0.73601194 |
| 75 | STK11 | 0.73090627 |
| 76 | TAOK1 | 0.72731672 |
| 77 | STK38 | 0.72455982 |
| 78 | ICK | 0.72331648 |
| 79 | FGFR3 | 0.71812230 |
| 80 | SGK1 | 0.71682684 |
| 81 | RPS6KC1 | 0.70525654 |
| 82 | RPS6KL1 | 0.70525654 |
| 83 | TAOK2 | 0.70486091 |
| 84 | CDK8 | 0.70200786 |
| 85 | LCK | 0.69535780 |
| 86 | MAP3K1 | 0.69110093 |
| 87 | RPS6KA2 | 0.68678640 |
| 88 | TNK2 | 0.68586976 |
| 89 | MAPK15 | 0.67121805 |
| 90 | RET | 0.66593990 |
| 91 | PRKCH | 0.64669983 |
| 92 | JAK2 | 0.64553884 |
| 93 | GRK7 | 0.63926471 |
| 94 | PIK3CG | 0.63040875 |
| 95 | CDK19 | 0.61442212 |
| 96 | GRK6 | 0.61138706 |
| 97 | RAF1 | 0.61107220 |
| 98 | JAK1 | 0.60459622 |
| 99 | PDGFRA | 0.58895363 |
| 100 | CAMK2A | 0.58449240 |
| 101 | RPS6KA6 | 0.58057930 |
| 102 | BMX | 0.56632012 |
| 103 | SGK494 | 0.55598507 |
| 104 | SGK223 | 0.55598507 |
| 105 | LYN | 0.53939465 |
| 106 | PRKD2 | 0.50669505 |
| 107 | DYRK1B | 0.50043971 |
| 108 | CDK3 | 0.49019094 |
| 109 | CAMKK2 | 0.48752793 |
| 110 | JAK3 | 0.48390415 |
| 111 | NTRK1 | 0.48110695 |
| 112 | MARK3 | 0.47939002 |
| 113 | PRKCG | 0.46568065 |
| 114 | MAPK7 | 0.46432406 |
| 115 | DDR2 | 0.45146228 |
| 116 | PDGFRB | 0.44364505 |
| 117 | TNIK | 0.43320858 |
| 118 | PRKCE | 0.43246906 |
| 119 | MATK | 0.42622696 |
| 120 | EPHA3 | 0.42463800 |
| 121 | LATS2 | 0.41807448 |
| 122 | MUSK | 0.40108610 |
| 123 | HCK | 0.37600030 |
| 124 | KDR | 0.37333010 |
| 125 | FGFR4 | 0.36557148 |
| 126 | IKBKE | 0.36547108 |
| 127 | DYRK1A | 0.35773616 |
| 128 | PDK1 | 0.35512481 |
| 129 | MAP3K2 | 0.35354531 |
| 130 | MAPK12 | 0.32767898 |
| 131 | SGK3 | 0.31675438 |
| 132 | MAPK13 | 0.31460509 |
| 133 | STK24 | 0.31399663 |
| 134 | CDC42BPA | 0.31278239 |
| 135 | MAP2K1 | 0.30669320 |
| 136 | MAPK10 | 0.30441794 |
| 137 | MOS | 0.30291953 |
| 138 | MAP3K6 | 0.29424392 |
| 139 | TXK | 0.27902840 |
| 140 | PRKAA2 | 0.27258436 |
| 141 | TBK1 | 0.26354373 |
| 142 | SGK2 | 0.26262698 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.46941850 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.19195686 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.18328119 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.10439142 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.04855328 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 1.99008331 |
| 7 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.93977639 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.92822184 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.85235538 |
| 10 | Asthma_Homo sapiens_hsa05310 | 1.69508824 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 1.67966685 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 1.62909166 |
| 13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.62234210 |
| 14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.62052565 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.59927595 |
| 16 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.54852932 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.54708770 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.54661344 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.54389562 |
| 20 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.54148993 |
| 21 | GABAergic synapse_Homo sapiens_hsa04727 | 1.53907530 |
| 22 | Taste transduction_Homo sapiens_hsa04742 | 1.53442096 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.53420662 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.50215988 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.48562381 |
| 26 | Insulin secretion_Homo sapiens_hsa04911 | 1.42608651 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.42311135 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.42040764 |
| 29 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.41793463 |
| 30 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.41097009 |
| 31 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.40178906 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.39708588 |
| 33 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.34438390 |
| 34 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.32606831 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.29240667 |
| 36 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.26917984 |
| 37 | Cocaine addiction_Homo sapiens_hsa05030 | 1.24901029 |
| 38 | Long-term depression_Homo sapiens_hsa04730 | 1.23526612 |
| 39 | Glioma_Homo sapiens_hsa05214 | 1.23116567 |
| 40 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.23108187 |
| 41 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.22968114 |
| 42 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.21018240 |
| 43 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.20614325 |
| 44 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.20469197 |
| 45 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.15440766 |
| 46 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.15065724 |
| 47 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.09776450 |
| 48 | Influenza A_Homo sapiens_hsa05164 | 1.09378629 |
| 49 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.07424638 |
| 50 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.06763981 |
| 51 | Prion diseases_Homo sapiens_hsa05020 | 1.06318295 |
| 52 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.06078958 |
| 53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.06041068 |
| 54 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.05012473 |
| 55 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.04527659 |
| 56 | Viral myocarditis_Homo sapiens_hsa05416 | 1.03581532 |
| 57 | Axon guidance_Homo sapiens_hsa04360 | 1.02726607 |
| 58 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.01430086 |
| 59 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.99006782 |
| 60 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.97242417 |
| 61 | Amoebiasis_Homo sapiens_hsa05146 | 0.96865989 |
| 62 | Melanogenesis_Homo sapiens_hsa04916 | 0.96023625 |
| 63 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.95456587 |
| 64 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.93587684 |
| 65 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.93338147 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.91137675 |
| 67 | Lysosome_Homo sapiens_hsa04142 | 0.90849228 |
| 68 | Gap junction_Homo sapiens_hsa04540 | 0.90127917 |
| 69 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89731893 |
| 70 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.89657978 |
| 71 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.89595216 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.88006968 |
| 73 | Adherens junction_Homo sapiens_hsa04520 | 0.87774460 |
| 74 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.87042970 |
| 75 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.86283929 |
| 76 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.86128169 |
| 77 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.86075570 |
| 78 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.85917574 |
| 79 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.84974212 |
| 80 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.84928182 |
| 81 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.84603471 |
| 82 | Salmonella infection_Homo sapiens_hsa05132 | 0.84281925 |
| 83 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.84224223 |
| 84 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.82964285 |
| 85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82204450 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81119257 |
| 87 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.80852953 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.80700771 |
| 89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80140095 |
| 90 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.78326112 |
| 91 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.78071724 |
| 92 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.77275377 |
| 93 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.76965651 |
| 94 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.76064039 |
| 95 | Legionellosis_Homo sapiens_hsa05134 | 0.73528410 |
| 96 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.73487547 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.71834359 |
| 98 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.71749144 |
| 99 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.71297945 |
| 100 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.70370195 |
| 101 | Measles_Homo sapiens_hsa05162 | 0.70356736 |
| 102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.70283644 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68154573 |
| 104 | Colorectal cancer_Homo sapiens_hsa05210 | 0.67309217 |
| 105 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.67013542 |
| 106 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.66647385 |
| 107 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66630559 |
| 108 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66616661 |
| 109 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.66246708 |
| 110 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65866146 |
| 111 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65000579 |
| 112 | Platelet activation_Homo sapiens_hsa04611 | 0.64995669 |
| 113 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.64992556 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.64821855 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63963338 |
| 116 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.63721675 |
| 117 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.63241611 |
| 118 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.62434837 |
| 119 | Focal adhesion_Homo sapiens_hsa04510 | 0.62400282 |
| 120 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.62381088 |
| 121 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62212948 |
| 122 | Leishmaniasis_Homo sapiens_hsa05140 | 0.62183381 |
| 123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61922477 |
| 124 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.60976877 |
| 125 | Phagosome_Homo sapiens_hsa04145 | 0.60294899 |
| 126 | Hepatitis C_Homo sapiens_hsa05160 | 0.59943406 |
| 127 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.59765831 |
| 128 | Hepatitis B_Homo sapiens_hsa05161 | 0.58164206 |
| 129 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.58135648 |
| 130 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.57687850 |
| 131 | Shigellosis_Homo sapiens_hsa05131 | 0.57649336 |
| 132 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57456753 |
| 133 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55987489 |
| 134 | Circadian rhythm_Homo sapiens_hsa04710 | 0.55106699 |
| 135 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55013158 |
| 136 | Tuberculosis_Homo sapiens_hsa05152 | 0.54459219 |

